Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
M

ASCO® 2023 Insights: "Chemo-Free Treatment With Inotuzumab Ozogamicin & Blinatumomab for Older Adults With Newly Diagnosed, Ph-, CD22+ B-ALL (Alliance A041703)"

By Insights from 2023 ASCO® Annual Meeting FEATURING Matthew Wieduwilt
By Insights from 2023 ASCO® Annual Meeting FEATURING Matthew Wieduwilt
121 views
June 20, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

19:47
Janssen Oncology

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Hematology
12:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Treatment Options for Patients With Myelo…

Feat. C. Cerchione
05:23
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Summary of Treatment Options for Patients…

Feat. C. Cerchione
04:24
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "RW Dosing Patterns & Outcomes Among C…

Feat. K. Rogers
09:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated TRIMM-2 Results - Talquetamab + D…

Feat. B. Dholaria
04:32
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 1b/2 CARTITUDE-1 Study Final Result…

Feat. Y. Lin
06:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From EPCORE NHL-1 - Effec…

Feat. Y. Karimi
10:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…

Feat. R. Merryman
20:11
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A …

Feat. A. Jakubowiak
09:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Outcomes of 3- vs. 5-Day Schedule of Cons…

Feat. S. Rangaraju
12:24
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R …

Feat. S. Kambhampati
11:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "First Phase 3 Results From CARTITUDE-4 - …

Feat. B. Dhakal
10:37
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Outcomes of 10-Day Decitabine With Veneto…

Feat. A. Coltoff
06:51
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy of COVID Vaccinations in Patient…

Feat. K. Rogers
14:34
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "IMerge - Results From a Ph3 Study of Imet…

Feat. A. Zeidan
14:44
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Chemo-Free Treatment With Inotuzumab Ozog…

Feat. M. Wieduwilt
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
05:00
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of MOLTO, a Multicenter, Open Lab…

Feat. A. Frustaci
09:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KRd vs. Elotuzumab + KRd in Transplant-El…

Feat. S. Knop
03:40
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Safety With ≥12 Months of Pirto…

Feat. C. Coombs
12:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

Feat. S. O'Brien, C. Coombs
07:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…

Feat. L. Shune
06:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Safety and Efficacy of Standard of Care C…

Feat. D. Hansen
04:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Bridging Therapy on Outcome of …

Feat. A. Afrough
03:42
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation,…

Feat. G. Perini
12:33
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…

Feat. K. Patel
05:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 …

Feat. M. Della Porta
08:46
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selin…

Feat. H. Ali
11:54
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Betting on BCMA in Multiple Myeloma"

Feat. R. Vij
16:24
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Much Ado About ALL CAR-T - Highlights of …

Feat. R. Faramand
16:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Managing the Toxicities and Supportive Ca…

Feat. G. Mannis
10:15
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Ph1 Trial of Dose-Adjusted EPOCH + Inot…

Feat. N. Kopmar
08:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …

Feat. A. Mcdonald
06:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …

Feat. N. Shah
14:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…

Feat. H. Hashmi
06:00
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASC2ESCALATE: A US Phase 2, Single-Arm, D…

Feat. J. Cortés
08:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…

Feat. C. Flowers
15:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…

Feat. A. Evens
06:34
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Matching-Adjusted Indirect Comparison o…

Feat. A. Kittai
04:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PERSIST-2 Landmark OS Analysis - Spleen V…

Feat. H. Ajufo
16:14
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Merging Molecular and Aging Assessments t…

Feat. S. Grant
10:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of A041702, an Alliance Phase 3 S…

Feat. J. Woyach
11:35
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Phase I Study Results of PHE885, …

Feat. A. Sperling
05:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Radiation Oncology Perspective on Primary…

Feat. A. Ng
05:22
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Five-Year Follow-Up Update of Defined-Com…

Feat. E. Liang
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
12:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…

Feat. A. Patel
20:19
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …

Feat. A. Paulus
09:45
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …

Feat. M. Kamdar
09:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Long-Term Outcomes of Adults With R/R B-A…

Feat. B. Shah
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
02:52
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of …

Feat. M. Amaya